Gang Chen
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 23
-
- Ferroptosis and cancer prognosis 21
- Gallbladder and Bile Duct Disorders 12
- Molecular Biology top 2%
- RNA modifications and cancer 15
- Physiology top 2%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 16
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 29
-
- Hepatocellular Carcinoma Treatment and Prognosis 14
-
- Liver Disease Diagnosis and Treatment 13
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)Nature Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Gang Chen
307 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 1.9k
- Molecular Biology 3.7k
- Physiology 1.1k
- Oncology 934
Countries citing papers authored by Gang Chen
This map shows the geographic impact of Gang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Chen more than expected).
Fields of papers citing papers by Gang Chen
This network shows the impact of papers produced by Gang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Chen. The network helps show where Gang Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 19 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 0 | |
| 15 | 2021 | 7 | |
| 16 | 2019 | 33 | |
| 17 | 2018 | 13 | |
| 18 | 2018 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2004 | 37 |
About Gang Chen
Gang Chen is a scholar working on Cancer Research, Hepatology and Pathology and Forensic Medicine, having authored 323 papers that have together received 8.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (29 papers), Cancer-related molecular mechanisms research (23 papers), Ferroptosis and cancer prognosis (21 papers), Pancreatic and Hepatic Oncology Research (16 papers), RNA modifications and cancer (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (13 papers) and Gallbladder and Bile Duct Disorders (12 papers). The work is most often cited by research in Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Molecular Biology (3.7k citations). Gang Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Haitao Yu, Xiaozai Xie, Pengyi Guo, Yi Wang, Nasreen Khalil, Peng Huang, Piao Zhang, Yeru Chen, Hartmuth C. Kolb and Xiaoguang Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.